Literature DB >> 27573744

Preeclampsia.

Rohan D'Souza1, John Kingdom2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27573744      PMCID： PMC5088080          DOI： 10.1503/cmaj.151551

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

Review 1.  Committee Opinion Summary No. 638: First-Trimester Risk Assessment for Early-Onset Preeclampsia.

Authors: 
Journal:  Obstet Gynecol       Date:  2015-09       Impact factor: 7.661

2.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

Review 3.  Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.

Authors:  Jillian T Henderson; Evelyn P Whitlock; Elizabeth O'Connor; Caitlyn A Senger; Jamie H Thompson; Maya G Rowland
Journal:  Ann Intern Med       Date:  2014-05-20       Impact factor: 25.391

4.  Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease.

Authors:  Herbert Valensise; Barbara Vasapollo; Giulia Gagliardi; Gian Paolo Novelli
Journal:  Hypertension       Date:  2008-09-29       Impact factor: 10.190

Review 5.  Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.

Authors:  Emily Bartsch; Karyn E Medcalf; Alison L Park; Joel G Ray
Journal:  BMJ       Date:  2016-04-19
  5 in total
  2 in total

1.  Home Quarantine: A Double-Edged Sword During COVID-19 Pandemic for Hypertensive Disorders of Pregnancy and the Related Complications.

Authors:  Qin-Yu Cai; Yin Yang; Yong-Heng Wang; Han-Lin Cui; Xue-Peng Wu; Kai-Mai Liao; Xin Luo; Tai-Hang Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-09       Impact factor: 3.249

Review 2.  Pregnancy Outcomes in Systemic Vasculitides.

Authors:  Carolyn Ross; Rohan D'Souza; Christian Pagnoux
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.